Pierce High pH Reversed-Phase Peptide Fractionation Kit

Life Technologies Corporation has been awarded contract A207_PO-0490379 by the University of Virginia on October 10, 2026, with a cumulative contract value of $653. The contracting organization is a higher education institution located in Virginia. This procurement represents a purchase order-based transaction with the prime contractor responsible for fulfilling the University's requirements under the terms and conditions of the award.

The specific products and services to be delivered under this contract award are not detailed in the available documentation. Without additional procurement specifications or statement of work documentation, the nature of Life Technologies Corporation's deliverables cannot be determined from the information provided. Interested parties requiring detailed information regarding contract scope, period of performance, or place of performance should consult the complete contract documentation or contact the University of Virginia's procurement office directly.